Protalix BioTherapeutics Price Chart
Protalix BioTherapeutics Volume Chart
Protalix BioTherapeutics Market Segments
After Hours
+0.02(+0.71%)
| Open | $2.83 |
|---|---|
| Close | $2.85 |
| Low | $2.83 |
| Low Change | 0.00 (0.00%) |
| High | $2.85 |
| High Change | +0.02 (+0.71%) |
| Range | $0.02 |
| Volume | 2.51K |
| Dollar Volume | $7.15K |
Regular Trading Hours
-0.01(-0.18%)
| Open | $2.82 |
|---|---|
| Close | $2.82 |
| Low | $2.78 |
| Low Change | -0.04 (-1.42%) |
| High | $2.88 |
| High Change | +0.06 (+2.13%) |
| Range | $0.10 |
| Volume | 646.479K |
| Dollar Volume | $1.82M |
Premarket
-0.06(-2.16%)
| Open | $2.78 |
|---|---|
| Close | $2.72 |
| Low | $2.72 |
| Low Change | -0.06 (-2.16%) |
| High | $2.78 |
| High Change | +0.00 (+0.00%) |
| Range | $0.06 |
| Volume | 1.603K |
| Dollar Volume | $4.36K |
After Hours Yesterday
+0.00(+0.00%)
| Open | $2.79 |
|---|---|
| Close | $2.79 |
| Low | $2.79 |
| Low Change | 0.00 (0.00%) |
| High | $2.79 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 574 |
| Dollar Volume | $1.60K |
Regular Trading Hours Yesterday
-0.03(-1.06%)
| Open | $2.82 |
|---|---|
| Close | $2.79 |
| Low | $2.78 |
| Low Change | -0.05 (-1.60%) |
| High | $2.86 |
| High Change | +0.04 (+1.24%) |
| Range | $0.08 |
| Volume | 438.129K |
| Dollar Volume | $1.22M |
Premarket Yesterday
*No Trades in Segment
Protalix BioTherapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $2.81 |
|---|---|
| 10 Day Moving Average (SMA10) | $2.84 |
| 20 Day Moving Average (SMA20) | $2.93 |
| 50 Day Moving Average (SMA50) | $2.50 |
| 100 Day Moving Average (SMA100) | $2.23 |
| 200 Day Moving Average (SMA200) | $1.96 |
Protalix BioTherapeutics Statistics
| Average Volume (30 Days) | 1.62M |
|---|---|
| P/E Ratio (Current) | 41.29 |
| EPS (Current) | $0.07 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$11.69M |
| Cash Ratio | 0.62 |
| Current Ratio | 3.03 |
| Quick Ratio | 2.06 |
| Debt to Equity | 0.00 |
| Enterprise Value | $218.77M |
| EV to EBITDA | 28.12 |
| EV to Sales | 3.54 |
| Price to Book | 4.39 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 3.76 |
| Return on Assets | 0.07% |
| Return on Equity | 0.10% |
Protalix BioTherapeutics Stock Splits
There has been 1 stock split for Protalix BioTherapeutics (PLX). The reverse stock split occured on December 20, 2019 and reduced the outstanding shares at a ratio of 10:1.
| Date | Type | Ratio |
|---|---|---|
| Dec 20, 2019 | Reverse | 10:1 |
Protalix BioTherapeutics Dividends
There have been no dividends for Protalix BioTherapeutics (PLX).